Category: Antimicrobial Stewardship
Targeted therapy and antimicrobial stewardship in patients with febrile neutropenia is difficult because in the vast majority of cases, an organism is not identified, and patients are known to be high risk for serious infections. Antibiotic de-escalation in patients with neutropenic fever varies, with European guidelines recommending 72hr de-escalation and North American guidelines recommending continuation […]
Apr 9, 2018
ID Journal Club Presents… Molecular Rapid Diagnostic Tests Improve Clinical Outcome
Bloodstream infections are associated with high mortality. Blood cultures are a reliable and accurate method for the identification of bloodstream infections but can take up to 5 days or even more being finalized, leading to delays in initiation of effective antibiotic therapy. The Infectious Disease Society of America (IDSA) recommends the use of rapid diagnostic […]
Mar 19, 2018
Antimicrobial Stewardship Program Takes Patient Safety Personally
At Nebraska Medicine, our Antimicrobial Stewardship Program’s (ASP) clinical mission is to optimize the utilization of antimicrobial agents, thereby improving patient outcomes (by reducing the risk of adverse events and Clostridium difficile infection) and limiting the spread of antimicrobial resistance. These Antimicrobial Stewardship activities have been mandated by the Joint Commission and our program has […]
Mar 14, 2018
New Staff Spotlight – Danny Schroeder, PharmD
Tell us about the position you are starting: I have recently started my role at Nebraska Medicine Bellevue as an Antimicrobial Stewardship pharmacist. I reach out to physicians at Nebraska Medicine Bellevue to discuss antibiotic therapy and try to obtain the best and safest therapy for our patients here. In addition, I work with Dr. Jasmine […]
Mar 7, 2018
Stewardship-driven Ertapenem Restriction: Can Reduced Utilization Affect the Antibiogram?
In this article review we learn about the impact of a large-scale, multi-institutional Antimicrobial Stewardship Intervention on significantly reducing the overall use of ertapenem without subsequent downstream effect on carbapenem-resistant Enterobacteriaceae (CRE) non-susceptibility patterns. Delgado A, Gawrys GW, Duhon BM, Lee GC (2017). Impact of an Antimicrobial Stewardship Initiative on Ertapenem Use and Carbapenem Susceptibilities […]
Mar 1, 2018
Recent Comments